EXPAREL® Non-Opioid Pain Medication
Implant & Oral Surgery of Colorado Offers Novel Approach to Treating Postsurgical Pain With an Important Non-Opioid Option
At Implant & Oral Surgery of Colorado we strive to provide patients with improved recovery after surgery, and offering the latest, unique advances in pain management helps us achieve our goal.
Implant & Oral Surgery of Colorado is one of the first practices in the region to adopt a novel approach to treating pain after surgery that may help patients take fewer opioid pain medications, which can cause drowsiness, nausea, and other, often serious, side effects. Minimizing exposure to opioids is also important due to the potential risk of long-term use.
As part of this novel approach, doctors at Implant & Oral Surgery of Colorado are offering EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, non-opioid, numbing medication that is administered during the surgical procedure. The numbing medication in EXPAREL®, bupivacaine, is slowly released over time to provide long-lasting pain control for the first few days after surgery, when patients need it most. Because EXPAREL® is given during the procedure, directly into the surgical area, patients may need fewer doses of other pain medications after surgery, including opioids. In fact, EXPAREL® is proven to help patients use fewer opioids as they start their recovery.*
At Implant & Oral Surgery of Colorado EXPAREL® is being used in combination with other non-opioid pain medications in many common surgeries, including Dental Implants, Bone Grafting and Wisdom Teeth Removal. More than 5 million patients have received EXPAREL® since 2012.
Remember that you have a say in how your pain is treated after surgery. If you are considering having surgery, we encourage you to speak with your doctor to learn about how our new postsurgical pain management program might be right for you. Click here for a Discussion Guide that can help you and your doctor set realistic expectations about what your recovery experience may be like.
*The clinical benefit of the decrease in opioid consumption was not demonstrated in the pivotal trials.
EXPAREL® is indicated for single-dose infiltration in adults to produce post-surgical local analgesia and as an interscalene brachial plexus nerve block to produce post-surgical regional analgesia. Safety and efficacy have not been established in other nerve blocks.
Important Safety Information
EXPAREL® should not be used in obstetrical paracervical block anesthesia.
In studies where EXPAREL® was injected into the wound, the most common side effects were nausea, constipation, and vomiting.
In studies where EXPAREL® was injected near a nerve, the most common side effects were nausea, fever, and constipation.
EXPAREL® is not recommended to be used in patients younger than 18 years old or in pregnant women.
Tell your healthcare provider if you have liver disease, since this may affect how the active ingredient (bupivacaine) in EXPAREL® is eliminated from your body.
EXPAREL® should not be injected into the spine, joints, or veins.
The active ingredient in EXPAREL®:
- Can affect your nervous system and your cardiovascular system
- May cause an allergic reaction
- May cause damage if injected into your joints
- Can cause a rare blood disorder
Please refer to the full Prescribing Information here.
For more information, please visit www.EXPAREL.com/patient or call 1-855-RX-EXPAREL (793-9727).